CN / EN
联系我们
KYKJT
Siamycin I

Siamycin I

  • 80%,90%,95%,98%,99%
  • 询价

Siamycin I (BMY-29304) 是一种 21 残基的三环肽,是放线菌的次级代谢产物。Siamycin I 是一种 HIV 融合抑制剂,对于急性 1 型 HIV (HIV-1) 和 HIV-2 感染,ED50 为 0.05-5.7 μM。Siamycin I 以非竞争性方式通过 FsrC-FsrA 双组分调节系统抑制明胶酶和明胶酶生物合成激活信息素 (GBAP) 信号传导。Siamycin I 抑制 fsrBDC 和 gelE-sprE 转录物的表达。Siamycin I 是一种套索肽,可与脂质 II 相互作用并抑制细胞壁生物合成。Siamycin I 是一种抗生素,具有用于肠球菌感染研究的潜力。

产品信息

产品名称Siamycin I
产品描述Siamycin I (BMY-29304) is a 21-residue tricyclic peptide and a secondary metabolite of actinomycetes. Siamycin I is an HIV fusion inhibitor, with an ED50 of 0.05-5.7 μM against acute HIV type 1 (HIV-1) and HIV-2 infection. Siamycin I inhibits gelatinase and gelatinase biosynthesis-activating pheromone (GBAP) signaling in a non-competitive manner through the FsrC-FsrA two-component regulatory system. Siamycin I inhibits the expression of fsrBDC and gelE-sprE transcripts. Siamycin I is a lasso peptide that interacts with lipid II and inhibits cell wall biosynthesis. Siamycin I is an antibiotic with potential for research on enterococcal infections.
生物活性Siamycin I (BMY-29304), a 21-residue tricyclic peptide, is a secondary metabolite in actinomycetes. Siamycin I is a HIV fusion inhibitor with ED50s of 0.05 to 5.7 μM for acute HIV type 1 (HIV-1) and HIV-2 infections. Siamycin I inhibits the gelatinase and gelatinase biosynthesis-activating pheromone (GBAP) signaling via the FsrC-FsrA two-component regulatory system in a noncompetitive manner. Siamycin I suppresses the expression of both fsrBDC and gelE-sprE transcripts. Siamycin I, a lasso peptide, interacts with lipid II and inhibits cell wall biosynthesis. Siamycin I, an antibiotic, has the potential for enterococcal infections research.
分子式C97H131N23O26S4
CAS号164802-68-0
储存方式Please store the product under the recommended conditions in the Certificate of Analysis.
上一个:
Daptomycin
下一个:
LL-37, human
置顶